[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"upper-respiratory-infections\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:upper-respiratory-infections":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":4},"100554419","efficacy-of-two-nasal-products-based-on-diluted-seawater-in-the-treatment-of-upper-respiratory-infectionsconditions-100554419",false,"NCT06498843","Efficacy of Two Nasal Products Based on Diluted Seawater in the Treatment of Upper Respiratory Infections\u002FConditions","Clinical Evaluation of the Effectiveness of Nasal Pump Spray Medical Devices DM004 and DM020 Based on Diluted Seawater in the Treatment of Colds, Rhinitis, Sinusitis, and Other Upper Respiratory Infections\u002FConditions","Inclusion Criteria:\n\n* Autonomous adult, or minor with the consent of their legal representative\n* Adults and children from 3 months old\n* Ability of the patient (for adults) or their legal representative (for children) to follow the instructions for product use\n* Having signed a free and informed consent to participate in the study expressed by the patient (for adults) or by their legal representative (for children) after being informed by the doctor.\n* Person with an upper respiratory tract infection (cold, rhinitis, rhinopharyngitis…) with symptoms of nasal congestion and nasal discharge of moderate to severe intensity (Jackson derived score (nasal congestion + nasal discharge) ≥ 4 on Day 0).\n* Persons with symptoms that started no more than 48 hours before the first visit\n\nExclusion Criteria:\n\n* Person not showing cold symptoms, particularly no nasal congestion (chronic dry rhinitis, or Jackson derived score (nasal congestion + nasal discharge) \\< 4 on Day 0).\n* Person undergoing treatment with a cortisone derivative, mucolytic, or medication containing pseudoephedrine or a similar product acting on nasal congestion or having used such a product within the 3 days preceding inclusion.\n* Person having used a nasal wash product within the 3 days preceding inclusion.\n* Person whose ability to use the product daily and complete the daily follow-up diary is in doubt.\n* Person refusing to sign the informed consent form prior to the study.\n* Person participating or having participated in any other clinical study within the 30 days preceding the study.\n* Person participating in any other clinical study.","ALL","3 Months",{"count":19,"type":20},91,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this interventional clinical trial is to test the safety and efficacy of two medical devices in subjects aged from 3 months old for the treatment of colds, rhinitis, sinusitis, and other upper respiratory infections\u002Fconditions for 7 days.",[26,27,28,29],"Rhinitis","Sinusitis","Upper Respiratory Infections","Colds","NOT_YET_RECRUITING","2024-07-31",{"date":33,"type":34},"2024-08-02","ACTUAL",{"date":36,"type":20},"2025-01",{"date":38,"type":20},"2025-06",{"name":40,"class":41},"YSLab","INDUSTRY"]